Pharvaris N.V.PHVSNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-36.1%
5Y CAGR-29.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-36.1%/yr
Annual compound
5Y CAGR
-29.5%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 50.37% |
| 2023 | 6.82% |
| 2022 | 59.89% |
| 2021 | 193.14% |
| 2020 | 140.53% |
| 2019 | 289.52% |
| 2018 | 0.00% |
| 2017 | 0.00% |